Christopher Marai Profile - Nomura Analyst
249 Followers
Christopher Marai Nomura
Wall Street Analyst
Success Rate
174 out of 394 ratings made a profit
Average Return
+3.60%
Average return per rating
Time Frame
Compare to
Copying Christopher Marai's trades since 2014 and holding each position for 1 Year would result in 44.16% of your transactions generating a profit, with an average return of 3.6% per rating.
Stock Rating Distribution
81.99% Buy
12.30% Hold
5.71% Sell
Distribution of Christopher Marai's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
Best Rating
The most profitable rating made by Christopher Marai
Christopher Marai's Stock Coverage
Insmed
May 14, 2014
Hold
Assigned
―
3Ratings
+20.10%
Novavax
May 14, 2014
Hold
Assigned
―
1Ratings
―
0.00%
Addex Therapeutics
May 14, 2014
Hold
Assigned
―
1Ratings
―
0.00%
Fortress Biotech
May 14, 2014
Hold
Assigned
―
3Ratings
―
0.00%
Protalix
Sep 19, 2014
Hold
Assigned
―
1Ratings
―
0.00%
Curis
Dec 01, 2014
Buy
Assigned
$3.00
(-35.21% Downside)
5Ratings
+63.87%
Oncolytics Biotech
Jul 02, 2015
Hold
Assigned
―
1Ratings
―
0.00%
Vertex Pharmaceuticals
Jul 10, 2015
Hold
Assigned
―
1Ratings
―
0.00%
Verastem
Nov 10, 2015
Hold
Reiterated
―
22Ratings
―
0.00%
Affimed
Nov 19, 2015
Buy
Reiterated
$19.00
―
2Ratings
-63.55%
List of latest recommendations made by Christopher Marai. Click to expand and see Christopher Marai's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
Christopher Marai activity FAQ
What is the performance of Christopher Marai's recommendations?
The percentage of profitable recommendations made by Christopher Marai is 44%, and the average return per transaction is 3.60%.
What was Christopher Marai's most profitable rating?
Christopher Marai’s most profitable ratings was a buy on PRTA stock on Jul 09, 2020 - Jul 09, 2021. The return on the trade was +390.30%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here